NR565 WEEK 4 MIDTERM ADVANCED
PHARMACOLOGY FINAL BANK 2026
TESTED ANSWERS GRADED A+
⩥ Question Type.
Answer: Multiple Choice
⩥ Number of Questions.
Answer: 100
⩥ Time Allotted.
Answer: 120 minutes (1.2 minutes per question)
⩥ Testing Timeframe.
Answer: The final exam will be available starting on Wednesday Week 8
at 12:01 am MT until Saturday Week 8 at 11:59 pm MT.
⩥ Week 5 Coverage.
Answer: Pharmacotherapy for Endocrine Disorders
⩥ Radioactive iodine adverse effects.
Answer: Hypothyroidism due to excessive thyroid damage (delayed)
, ⩥ Hypothyroidism incidence.
Answer: Up to 90% of patients have hypothyroidism within the first year
after exposure
⩥ Methimazole indication.
Answer: First-line for hyperthyroidism, except for pregnant or
breastfeeding patients
⩥ Methimazole MOA.
Answer: Prevents oxidation of iodide, inhibiting incorporation of iodine
into tyrosine; prevents iodinated tyrosines from coupling
⩥ Levothyroxine education.
Answer: Take once daily 30 to 60 minutes before breakfast. Separate by
4 hours from drugs such as H2 receptor blockers, PPIs, antacids, iron
and calcium.
⩥ Levothyroxine monitoring.
Answer: Target TSH is 0.4 to 4
⩥ Pioglitazone contraindications.
Answer: NYHA class III and IV; Type 1 DM (needs insulin to work)
PHARMACOLOGY FINAL BANK 2026
TESTED ANSWERS GRADED A+
⩥ Question Type.
Answer: Multiple Choice
⩥ Number of Questions.
Answer: 100
⩥ Time Allotted.
Answer: 120 minutes (1.2 minutes per question)
⩥ Testing Timeframe.
Answer: The final exam will be available starting on Wednesday Week 8
at 12:01 am MT until Saturday Week 8 at 11:59 pm MT.
⩥ Week 5 Coverage.
Answer: Pharmacotherapy for Endocrine Disorders
⩥ Radioactive iodine adverse effects.
Answer: Hypothyroidism due to excessive thyroid damage (delayed)
, ⩥ Hypothyroidism incidence.
Answer: Up to 90% of patients have hypothyroidism within the first year
after exposure
⩥ Methimazole indication.
Answer: First-line for hyperthyroidism, except for pregnant or
breastfeeding patients
⩥ Methimazole MOA.
Answer: Prevents oxidation of iodide, inhibiting incorporation of iodine
into tyrosine; prevents iodinated tyrosines from coupling
⩥ Levothyroxine education.
Answer: Take once daily 30 to 60 minutes before breakfast. Separate by
4 hours from drugs such as H2 receptor blockers, PPIs, antacids, iron
and calcium.
⩥ Levothyroxine monitoring.
Answer: Target TSH is 0.4 to 4
⩥ Pioglitazone contraindications.
Answer: NYHA class III and IV; Type 1 DM (needs insulin to work)
